新医学
新醫學
신의학
NEW CHINESE MEDICINE
2013年
11期
743-747
,共5页
朱海鹏%彭亮%王培培%杜巍%殷思纯%李发武
硃海鵬%彭亮%王培培%杜巍%慇思純%李髮武
주해붕%팽량%왕배배%두외%은사순%리발무
羊水%脐带%骨髓%间充质干细胞%免疫抑制
羊水%臍帶%骨髓%間充質榦細胞%免疫抑製
양수%제대%골수%간충질간세포%면역억제
Amniotic fluid%Umbilical cord%Bone marrow%Mesenchymal stem cells%Immune sup-pression
目的:比较羊水来源间充质干细胞( AF-MSC)、脐带来源间充质干细胞( UC-MSC)和骨髓来源间充质干细胞( BM-MSC)对植物血凝素诱导的淋巴细胞增殖的抑制作用。方法从妊娠中期羊水、新生儿脱落脐带、正常成人骨髓中分离获取原代AF-MSC、 UC-MSC和 BM-MSC。观察形态并采用流式细胞术检测表面分子。取传代培养的第3代的AF-MSC、 UC-MSC和 BM-MSC体外诱导培养后,观察体外诱导成骨成脂多向分化情况。将不同细胞浓度的AF-MSC, UC-MSC和 BM-MSC分别加入到植物血凝素诱导的外周血淋巴细胞增殖体系中,比较3种不同来源的MSC对淋巴细胞增殖的调控作用。结果分离培养的AF-MSC, UC-MSC和BM-MSC分别表达MSC特异性表面分子CD29、CD70、 CD90,不表达造血干细胞表面分子CD45。体外传代培养的AF-MSC、 UC-MSC和BM-MSC对淋巴细胞增殖的抑制中,当淋巴细胞∶MSC为1∶1、1∶10、1∶50、1∶100时,对淋巴细胞增殖的抑制率AF-MSC最强, BM-MSC最弱。结论 AF-MSC、 UC-MSC和BM-MSC均具有抑制植物血凝素诱导淋巴细胞增殖的作用,其中以AF-MSC抑制效果最强, BM-MSC最弱,其抑制效果与MSC数量有关。
目的:比較羊水來源間充質榦細胞( AF-MSC)、臍帶來源間充質榦細胞( UC-MSC)和骨髓來源間充質榦細胞( BM-MSC)對植物血凝素誘導的淋巴細胞增殖的抑製作用。方法從妊娠中期羊水、新生兒脫落臍帶、正常成人骨髓中分離穫取原代AF-MSC、 UC-MSC和 BM-MSC。觀察形態併採用流式細胞術檢測錶麵分子。取傳代培養的第3代的AF-MSC、 UC-MSC和 BM-MSC體外誘導培養後,觀察體外誘導成骨成脂多嚮分化情況。將不同細胞濃度的AF-MSC, UC-MSC和 BM-MSC分彆加入到植物血凝素誘導的外週血淋巴細胞增殖體繫中,比較3種不同來源的MSC對淋巴細胞增殖的調控作用。結果分離培養的AF-MSC, UC-MSC和BM-MSC分彆錶達MSC特異性錶麵分子CD29、CD70、 CD90,不錶達造血榦細胞錶麵分子CD45。體外傳代培養的AF-MSC、 UC-MSC和BM-MSC對淋巴細胞增殖的抑製中,噹淋巴細胞∶MSC為1∶1、1∶10、1∶50、1∶100時,對淋巴細胞增殖的抑製率AF-MSC最彊, BM-MSC最弱。結論 AF-MSC、 UC-MSC和BM-MSC均具有抑製植物血凝素誘導淋巴細胞增殖的作用,其中以AF-MSC抑製效果最彊, BM-MSC最弱,其抑製效果與MSC數量有關。
목적:비교양수래원간충질간세포( AF-MSC)、제대래원간충질간세포( UC-MSC)화골수래원간충질간세포( BM-MSC)대식물혈응소유도적림파세포증식적억제작용。방법종임신중기양수、신생인탈락제대、정상성인골수중분리획취원대AF-MSC、 UC-MSC화 BM-MSC。관찰형태병채용류식세포술검측표면분자。취전대배양적제3대적AF-MSC、 UC-MSC화 BM-MSC체외유도배양후,관찰체외유도성골성지다향분화정황。장불동세포농도적AF-MSC, UC-MSC화 BM-MSC분별가입도식물혈응소유도적외주혈림파세포증식체계중,비교3충불동래원적MSC대림파세포증식적조공작용。결과분리배양적AF-MSC, UC-MSC화BM-MSC분별표체MSC특이성표면분자CD29、CD70、 CD90,불표체조혈간세포표면분자CD45。체외전대배양적AF-MSC、 UC-MSC화BM-MSC대림파세포증식적억제중,당림파세포∶MSC위1∶1、1∶10、1∶50、1∶100시,대림파세포증식적억제솔AF-MSC최강, BM-MSC최약。결론 AF-MSC、 UC-MSC화BM-MSC균구유억제식물혈응소유도림파세포증식적작용,기중이AF-MSC억제효과최강, BM-MSC최약,기억제효과여MSC수량유관。
Objective To compare the inhibitory effect of amniotic fluid-derived mesenchymal stem cells ( AF-MSC) , umbilical cord blood mesenchymal stem cells ( UC-MSC ) and bone marrow Mesenchymal stem cells ( BM-MSC) on phytohemagglutinin ( PHA) -induced lymphocyte proliferation.Methods Human mesenchymal stem cells from the second trimester amniotic fluid , umbilical cord and normal adult bone mar-row, flow cytometry were extracted and detected the surface molecules of MSC.Induce the MSCs differentiate into osteogenic like and adipogenic like cells in virto.AF-MSC, UC-MSC and BM-MSC were added to PHA-in-duced lymphocyte proliferation system at different ratio , compared inhibitory effect of three different sources-de-rived mesenchymal stem cells on lymphocyte proliferation.Results Mesenchymal stem cell-specific surface molecules CD29, CD70 and CD90 were expressed by isolated AF-MSC, UC-MSC and BM-MSC, respectively.However, hematopoietic stem cell surface molecule CD 45 was not expressed.In vitro cultures of AF-MSC, UC-MSC and BM-MSC on lymphocyte proliferation inhibition , when lymphocytes: mesenchymal stem cells 1: 1, 1: 10, 1: 50, 1: 100, the right lymphocyte proliferation inhibition rate AF-MSC strongest, BM-MSC wea-kest.Whenever the of ratio of lymphocytes and mesenchymal stem cells are 1: 1, 1: 10, 1: 50, 1: 100, the lymphocyte proliferation inhibition of AF-MSC is strongest , and BM-MSC is weakest.Conclusion AF-MSC, UC-MSC and BM-MSC can inhibit PHA-induced lymphocyte proliferation , in which the AF-MSC is the strongest and BM-MSC is the weakest.Further study indicates that the effect was associated with the number of ratio of MSC to LC.